Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Virtual Booth

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

1DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Ibafloxacine, 91618-36-9, Ibaflin, R-835, S-25930, R835

Molecular Formula

C₁₅H₁₄FNO₃

Molecular Weight

275.27 g/mol

InChI Key

DXKRGNXUIRKXNR-UHFFFAOYSA-N

FDA UNII

53VPK9R0T5

1 2D Structure

Ibafloxacin

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

7-fluoro-8,12-dimethyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic acid

2.1.2 InChI

InChI=1S/C15H14FNO3/c1-7-3-4-9-8(2)12(16)5-10-13(9)17(7)6-11(14(10)18)15(19)20/h5-7H,3-4H2,1-2H3,(H,19,20)

2.1.3 InChI Key

DXKRGNXUIRKXNR-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC1CCC2=C3N1C=C(C(=O)C3=CC(=C2C)F)C(=O)O

2.2 Other Identifiers

2.2.1 UNII

53VPK9R0T5

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1h,5h-benzo(i,j)quinolizine-2-carboxylic Acid

2. S 25930

3. S-25930

2.3.2 Depositor-Supplied Synonyms

1. Ibafloxacine

2. 91618-36-9

3. Ibaflin

4. R-835

5. S-25930

6. R835

7. 53vpk9r0t5

8. R 835

9. R835;s25930

10. S25930

11. 9-fluoro-6,7-dihydro-5,8-dimethyl-1-oxo-1h,5h-benzo(ij)quinolizine-2-carboxylic Acid

12. S 25930

13. Ibafloxacino

14. Ibafloxacinum

15. 1h,5h-benzo(ij)quinolizine-2-carboxylic Acid, 9-fluoro-6,7-dihydro-5,8-dimethyl-1-oxo-

16. Ibafloxacine [inn-french]

17. Ibafloxacinum [inn-latin]

18. Ibafloxacino [inn-spanish]

19. Unii-53vpk9r0t5

20. Ibafloxacin [usan:inn:ban]

21. 1h,5h-benzo[ij]quinolizine-2-carboxylic Acid, 9-fluoro-6,7-dihydro-5,8-dimethyl-1-oxo-

22. Ibafloxacin [mi]

23. Ibafloxacin [inn]

24. Ibafloxacin (usan/inn)

25. Ibafloxacin [usan]

26. Dsstox_cid_31642

27. Dsstox_rid_97526

28. Ibafloxacin [mart.]

29. Dsstox_gsid_57853

30. Schembl154637

31. Chembl170052

32. Dtxsid8057853

33. Gtpl10819

34. Tox21_113686

35. Hy-u00214

36. Cs-7344

37. Fluoro-dimethyl-oxo-[?]carboxylic Acid

38. 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1h,5h-benzo[ij]quinolizine-2-carboxylic Acid

39. Ibafloxacin [ema Epar Veterinary]

40. Ncgc00249910-01

41. Cas-91618-36-9

42. D04485

43. Q5983609

44. 6,7-dihydro-5,8-dimethyl-9- Fluoro-1-oxo-1h,5h-benzo[ij]quinolizine-2-carboxylic Acid

45. 7-fluoro-8,12-dimethyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic Acid

2.4 Create Date

2005-08-01

3 Chemical and Physical Properties

Molecular Formula	C₁₅H₁₄FNO₃
Molecular Weight	275.27 g/mol
XLogP3	3.3
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	1
Exact Mass	275.09577147 g/mol
Monoisotopic Mass	275.09577147 g/mol
Topological Polar Surface Area	57.6 Å²
Heavy Atom Count	20
Formal Charge	0
Complexity	490
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Drug Indication

* Dogs: :

Ibaflin is indicated for the treatment of the following conditions in dogs:

- dermal infections (pyoderma - superficial and deep, wounds, abscesses) caused by susceptible strains of Staphylococci, Escherichia coli and Proteus mirabilis;

- acute, uncomplicated urinary-tract infections, caused by susceptible strains of Staphylococci, Proteus species, Enterobacter spp. , E. coli and Klebsiella spp. ;

- respiratory-tract infections (upper tract) caused by susceptible strains of Staphylococci, E. coli, and Klebsiella spp.

Ibaflin gel is indicated in dogs for the treatment of the following conditions:

- dermal infections (pyoderma - superficial and deep, wounds, abscesses) caused by susceptible pathogens such as Staphylococcus spp. , E. coli and P. mirabilis.

* Cats: :

Ibaflin gel is indicated in cats for treatment of the following conditions:

- dermal infections (soft-tissue infections - wounds, abscesses) caused by susceptible pathogens such as Staphylococcus spp. , E. coli, Proteus spp. and Pasteurella spp. ;

- upper respiratory-tract infections caused by susceptible pathogens such as Staphylococcus spp. , E. coli, Klebsiella spp. and Pasteurella spp.

5 Pharmacology and Biochemistry

5.1 ATC Code

QJ01MA96

Drugs in Development

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Find Ibafloxacin manufacturers, exporters & distributors on PharmaCompass

R 835

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

DEVELOPMENTS

1 Drugs in Development

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

1DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

What are you looking for?